Ameritas Investment Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $720K | Sell |
1,863
-126
| -6% | -$46.7K | 0.02% | 760 |
|
|
2026
Q1 | $582K | Hold |
1,989
| – | – | 0.02% | 790 |
|
|
2025
Q4 | $697K | Sell |
1,989
-63
| -3% | -$21.3K | 0.02% | 719 |
|
|
2025
Q3 | $663K | Sell |
2,052
-81
| -4% | -$25.2K | 0.02% | 725 |
|
|
2025
Q2 | $830K | Sell |
2,133
-77
| -3% | -$31K | 0.03% | 669 |
|
|
2025
Q1 | $961K | Sell |
2,210
-50
| -2% | -$20.1K | 0.03% | 619 |
|
|
2024
Q4 | $834K | Sell |
2,260
-89
| -4% | -$37.2K | 0.03% | 672 |
|
|
2024
Q3 | $1.22M | Sell |
2,349
-97
| -4% | -$51.8K | 0.04% | 555 |
|
|
2024
Q2 | $1.33M | Sell |
2,446
-95
| -4% | -$50.2K | 0.05% | 497 |
|
|
2024
Q1 | $1.32M | Sell |
2,541
-70
| -3% | -$34.8K | 0.05% | 524 |
|
|
2023
Q4 | $1.23M | Sell |
2,611
-109
| -4% | -$50.4K | 0.05% | 532 |
|
|
2023
Q3 | $1.18M | Sell |
2,720
-92
| -3% | -$41.7K | 0.05% | 501 |
|
|
2023
Q2 | $1.25M | Sell |
2,812
-103
| -4% | -$47.5K | 0.05% | 497 |
|
|
2023
Q1 | $1.34M | Hold |
2,915
| – | – | 0.05% | 460 |
|
|
2022
Q4 | $1.39M | Sell |
2,915
-72
| -2% | -$36.6K | 0.06% | 457 |
|
|
2022
Q3 | $1.36M | Sell |
2,987
-30
| -1% | -$14.4K | 0.06% | 385 |
|
|
2022
Q2 | $1.46M | Sell |
3,017
-79
| -3% | -$39.1K | 0.06% | 378 |
|
|
2022
Q1 | $1.52M | Sell |
3,096
-86
| -3% | -$39.3K | 0.05% | 434 |
|
|
2021
Q4 | $1.48M | Sell |
3,182
-101
| -3% | -$42.5K | 0.05% | 464 |
|
|
2021
Q3 | $1.22M | Sell |
3,283
-62
| -2% | -$23.6K | 0.04% | 518 |
|
|
2021
Q2 | $1.28M | Sell |
3,345
-44
| -1% | -$16.8K | 0.05% | 513 |
|
|
2021
Q1 | $1.22M | Sell |
3,389
-230
| -6% | -$74K | 0.05% | 523 |
|
|
2020
Q4 | $1.16M | Sell |
3,619
-228
| -6% | -$70K | 0.05% | 474 |
|
|
2020
Q3 | $1.03M | Sell |
3,847
-166
| -4% | -$44.7K | 0.05% | 446 |
|
|
2020
Q2 | $1.05M | Sell |
4,013
-124
| -3% | -$33.1K | 0.05% | 434 |
|
|
2020
Q1 | $939K | Sell |
4,137
-94
| -2% | -$25.6K | 0.05% | 395 |
|
|
2019
Q4 | $1.28M | Sell |
4,231
-78
| -2% | -$21.5K | 0.06% | 423 |
|
|
2019
Q3 | $1.03M | Sell |
4,309
-151
| -3% | -$41.4K | 0.05% | 487 |
|
|
2019
Q2 | $1.26M | Sell |
4,460
-177
| -4% | -$48.4K | 0.06% | 402 |
|
|
2019
Q1 | $1.33M | Buy |
4,637
+50
| +1% | +$14.5K | 0.06% | 387 |
|
|
2018
Q4 | $1.21M | Sell |
4,587
-187
| -4% | -$51.4K | 0.07% | 375 |
|
|
2018
Q3 | $1.31M | Sell |
4,774
-6
| -0.1% | -$1.56K | 0.06% | 415 |
|
|
2018
Q2 | $1.14M | Sell |
4,780
-530
| -10% | -$123K | 0.05% | 470 |
|
|
2018
Q1 | $1.17M | Sell |
5,310
-248
| -4% | -$58.3K | 0.06% | 457 |
|
|
2017
Q4 | $1.25M | Sell |
5,558
-418
| -7% | -$89K | 0.06% | 450 |
|
|
2017
Q3 | $1.17M | Hold |
5,976
| – | – | 0.06% | 464 |
|
|
2017
Q2 | $1.12M | Sell |
5,976
-106
| -2% | -$19K | 0.05% | 480 |
|
|
2017
Q1 | $1.01M | Sell |
6,082
-209
| -3% | -$33.2K | 0.05% | 516 |
|
|
2016
Q4 | $904K | Hold |
6,291
| – | – | 0.05% | 550 |
|
|
2016
Q3 | $788K | Buy |
6,291
+1,093
| +21% | +$141K | 0.04% | 586 |
|
|
2016
Q2 | $683K | Buy |
5,198
+245
| +5% | +$33.5K | 0.04% | 455 |
|
|
2016
Q1 | $688K | Hold |
4,953
| – | – | 0.05% | 438 |
|
|
2015
Q4 | $691K | Hold |
4,953
| – | – | 0.05% | 416 |
|
|
2015
Q3 | $693K | Hold |
4,953
| – | – | 0.05% | 392 |
|
|
2015
Q2 | $813K | Sell |
4,953
-82
| -2% | -$13.1K | 0.05% | 367 |
|
|
2015
Q1 | $777K | Hold |
5,035
| – | – | 0.05% | 395 |
|
|
2014
Q4 | $633K | Sell |
5,035
-124
| -2% | -$15.3K | 0.04% | 468 |
|
|
2014
Q3 | $617K | Sell |
5,159
-308
| -6% | -$35.3K | 0.04% | 471 |
|
|
2014
Q2 | $588K | Sell |
5,467
-115
| -2% | -$11.8K | 0.04% | 509 |
|
|
2014
Q1 | $556K | Sell |
5,582
-22,319
| -80% | -$2.02M | 0.04% | 523 |
|
|
2013
Q4 | $2.58M | Sell |
27,901
-185
| -0.7% | -$16.4K | 0.21% | 114 |
|
|
2013
Q3 | $2.35M | Buy |
28,086
+11,486
| +69% | +$984K | 0.22% | 110 |
|
|
2013
Q2 | $1.36M | Buy |
+16,600
| New | +$1.24M | 0.37% | 110 |
|
Other funds holding ELV
Ameritas Investment Partners's ELV Position: Q2 2026 in Review
Ameritas Investment Partners reduced its Elevance Health (ELV) stake by 6.3% in Q2 2026, selling an estimated $46.7K and leaving 1,863 shares worth $720K. The position accounts for 0.02% of the portfolio, ranked #760.
Ameritas Investment Partners first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.58M in Q4 2013. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Ameritas Investment Partners held 1,863 shares of Elevance Health worth $720K as of Q2 2026.
- Ameritas Investment Partners sold 126 Elevance Health shares in Q2 2026, an estimated $46.7K.
- Elevance Health made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #760 holding.
- Ameritas Investment Partners first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Ameritas Investment Partners's Elevance Health position peaked at $2.58M in Q4 2013.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.